Zhejiang Orient Gene Biotech Co Ltd (688298) — Financial Flexibility Index
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥31.69 Million (operating CF CN¥-30.52 Million minus capex CN¥62.20 Million) represents 0% of total liabilities (CN¥1.01 Billion). Check cash flow reinvestment rate of Zhejiang Orient Gene Biotech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Orient Gene Biotech Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Zhejiang Orient Gene Biotech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Zhejiang Orient Gene Biotech Co Ltd (688298) cash flow conversion.
Annual Financial Flexibility Index for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Zhejiang Orient Gene Biotech Co Ltd. Explore 688298 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | CN¥575.77 Million | CN¥-348.33 Million | CN¥1.30 Billion | ▲ +205.4% |
| 2023 | -0.42x | CN¥-606.03 Million | CN¥-1.60 Billion | CN¥1.45 Billion | ▼ -124.6% |
| 2022 | 1.70x | CN¥4.05 Billion | CN¥3.00 Billion | CN¥2.38 Billion | ▼ -37.8% |
| 2021 | 2.74x | CN¥5.71 Billion | CN¥5.20 Billion | CN¥2.09 Billion | ▲ +60.0% |
| 2020 | 1.71x | CN¥1.92 Billion | CN¥1.79 Billion | CN¥1.12 Billion | ▲ +177.6% |
| 2019 | 0.62x | CN¥66.11 Million | CN¥54.21 Million | CN¥107.38 Million | ▲ +26.3% |
| 2018 | 0.49x | CN¥63.20 Million | CN¥44.33 Million | CN¥129.62 Million | ▲ +25.9% |
| 2017 | 0.39x | CN¥46.93 Million | CN¥33.54 Million | CN¥121.20 Million | ▲ +234.7% |
| 2016 | 0.12x | CN¥16.46 Million | CN¥11.81 Million | CN¥142.28 Million | — |